Clinical Trials
14 trialsNCT07214324 2026-04-23
PNRR-2022-1237
Azienda USL Reggio Emilia - IRCCS
Recruiting
NCT04234022 2026-04-09
Zn-DDC to Target Hypoxia-NFkappaB-CSCs Pathway in Multiple Myeloma
The Royal Wolverhampton Hospitals NHS Trust
Recruiting
NCT07477912 2026-03-17
MSTH-CAR001
Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology
Phase 1/2 Recruiting
NCT07413809 2026-02-17
Prevention of Delayed CINV After Autologous Transplant: Olanzapine-Containing Regimen vs. Dexamethasone-Containing Regimen
The Affiliated People's Hospital of Ningbo University
Phase 3 Recruiting
NCT07139509 2025-11-25
UCAR-T_MM-XA
Xi'an No.3 Hospital
Phase 1 Recruiting
NCT06409767 2025-09-24
ALHERT
University Hospital, Angers
Phase NA Recruiting
NCT07014865 2025-08-29
MMYLIFE
Azienda USL Reggio Emilia - IRCCS
Recruiting
NCT07085559 2025-07-25
Safety and Efficacy of Metabolically Armed BCMA CAR-T Cells (Meta10-BCMA) in the Treatment of r/r Plasma Cell Neoplasms Clinical Research
Anhui Provincial Hospital
Phase EARLY_PHASE1 Recruiting
NCT06961669 2025-05-29
ECAR01
Anhui Provincial Hospital
Phase NA Recruiting
NCT06758713 2025-01-06
Safety and Efficacy of Fourth-Generation CAR-T in the Treatment of Hematologic Malignancies
The Third Affiliated Hospital of Southern Medical University
Phase 1 Recruiting
NCT06284395 2024-10-02
Two Schemes Response in Multiple Myeloma
Hospital General de Mexico
Recruiting
NCT06520176 2024-07-25
Comparison Study of EAP and CG Regimens for Mobilizing Hematopoietic Stem Cells in Multiple Myeloma Patients
The Affiliated People's Hospital of Ningbo University
Phase 3 Recruiting
NCT06515249 2024-07-23
Integrative Therapies in Multiple Myeloma
Bnai Zion Medical Center
Phase NA Recruiting
NCT05243212 2024-01-31
Study of CAR-BCMA, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against BCMA in Subjects With Multiple Myeloma
Sheba Medical Center
Phase 1/2 Recruiting